基于超声的列线图用于区分乳腺实性病变中的恶性肿瘤与结节性硬化性腺病
研究纳入训练队列156例(156个肿块)和独立验证队列162例(162个肿块),用最佳子集回归从超声特征和年龄中筛选6个预测因子构建列线图,训练队列C指数0.967(95%CI 0.941-0.993),验证队列C指数0.951(95%CI 0.919-0.983),校准良好,决策曲线分析显示临床有用。
要点
- 列线图纳入年龄、钙化、高回声晕、血供分布、肿瘤大小和乳腺实质厚度6个预测因子。
- 训练队列C指数0.967(95%CI 0.941-0.993),验证队列C指数0.951(95%CI 0.919-0.983)。
- 当同一患者存在多个结节性硬化性腺病与恶性肿瘤且BI-RADS分类相同时,列线图可作为BI-RADS的补充以精准活检最可能为恶性的肿块。
核心结论
- 当同一患者存在多个结节性硬化性腺病与恶性肿瘤肿块且被归入同一BI-RADS分类时,该列线图可作为BI-RADS分类的补充,用于精准活检最可能为恶性肿瘤的肿块。
研究设计与样本
- 训练队列纳入同一研究机构的156例患者(156个肿块),包含结节性硬化性腺病或恶性肿瘤。
- 采用最佳子集回归从超声特征和患者年龄中确定预测因子以构建列线图。
- 模型性能与临床效用采用Brier评分、一致性(C)指数、校准曲线和决策曲线分析评估。
- 独立验证队列由另一机构的162例患者(162个肿块)组成。
关键影像表现/征象
- 通过最佳子集回归选择6个预测因子构建列线图:年龄、钙化、高回声晕、血供分布、肿瘤大小和乳腺实质厚度。
诊断标准与关键数值
- 训练队列列线图Brier评分为0.068,C指数为0.967(95%CI 0.941-0.993)。
- 验证队列列线图C指数为0.951(95%CI 0.919-0.983),校准良好。
- 校准曲线显示预测与病理结果之间一致性良好。
- 决策曲线分析显示该模型具有临床实用性。
临床应用与阅片要点
- 作者认为,当同一患者存在多个结节性硬化性腺病与恶性肿瘤肿块且归入同一BI-RADS分类时,列线图可作为BI-RADS分类的补充,用于精准活检最可能为恶性肿瘤的肿块。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Nodular sclerosing adenoses (NSAs) and malignant tumors (MTs) may coexist and are often classified into the same Breast Imaging Reporting and Data System (BI-RADS) category. We aimed to build and validate an ultrasound-based nomogram to distinguish MT from NSA for building a precise sequence of biopsies.
MATERIALS AND METHODS: The training cohort included 156 patients (156 masses) with NSA or MT at one study institution. We used best subset regression to determine the predictors for building a nomogram from ultrasonic characteristics and patients' age. Model performance and clinical utility were evaluated using Brier score, concordance (C)-index, calibration curve, and decision curve analysis. The independent validation cohort consisted of 162 patients (162 masses) from a separate institution.
RESULTS: Through best subset regression, we selected 6 predictors to develop nomogram: age, calcification, echogenic rim, vascularity distribution, tumor size, and thickness of breast parenchyma. Brier score and C-index of the nomogram in the training cohort were 0.068 and 0.967 (95% confidence interval [CI]: 0.941-0.993), respectively. In addition, calibration curve demonstrated good agreement between prediction and pathological result. In the validation cohort, the nomogram still obtained a favorable C-index score of 0.951 (95% CI: 0.919-0.983) and fine calibration. Decision curve analysis showed that the model was clinically useful.
CONCLUSIONS: If multiple NSA and MT masses are present in the same patient and are classified into the same BI-RADS category, our nomogram can be used as a supplement to the BI-RADS category for accurate biopsy of the mass most likely to be MT.
引用
- Liang T, Cong S, Yi Z, et al. Ultrasound-Based Nomogram for Distinguishing Malignant Tumors from Nodular Sclerosing Adenoses in Solid Breast Lesions. J Ultrasound Med. 2021. PMID: 33438775. doi:10.1002/jum.15612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。